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Abstract. Modern approaches to diagnostics of osteoporosis and ischemia in women after menopause under 
conditions of primary medical and sanitary aid. Bugrim T.V. Problem of osteoporosis has gained a special 
significance especially in the last years’ period. In postmenopausal period women suffer not only from osteoporosis 
(OP) but of increased incidence of cardiovascular diseases, including ischemic heart disease (IHD). The aim of this 
investigation was to carry out the diagnostics of OP and ischemic manifestation in women of postmenopause period by 
modern methods. 85 women aged 45-65 years with physiological and pathological climax were included in the 
investigation. Diagnostic of OP was carried out basing on the bone mineral density evaluation by X-ray Duoenergetic 
absorption. Diagnostic of IHD was carried out by veloergometry, evaluating stenocardia clinical manifestations and 
functional class. As a result it was established that 57,1% women in a postmenopausal period suffered both from 
osteoporosis and ischemic heart disease. Diagnostic of OP and IHD confirmed presence of changes in bone and 
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